On Tuesday, Upstream Bio Inc (NASDAQ: UPB) was -5.41% drop from the session before settling in for the closing price of $8.68. A 52-week range for UPB has been $5.14 – $29.46.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 47.97% over the past five years. When this article was written, the company’s average yearly earnings per share was at 54.67%. With a float of $19.17 million, this company’s outstanding shares have now reached $53.64 million.
Let’s look at the performance matrix of the company that is accounted for 52 employees. In terms of profitability, gross margin is 100.0%, operating margin of -3565.33%, and the pretax margin is -2938.14%.
Upstream Bio Inc (UPB) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Upstream Bio Inc stocks. The insider ownership of Upstream Bio Inc is 64.29%, while institutional ownership is 40.17%. The most recent insider transaction that took place on Oct 15 ’24, was worth 14,025,000. In this transaction Director of this company bought 825,000 shares at a rate of $17.00, taking the stock ownership to the 4,554,873 shares. Before that another transaction happened on Oct 15 ’24, when Company’s Director bought 825,000 for $17.00, making the entire transaction worth $14,025,000. This insider now owns 4,554,873 shares in total.
Upstream Bio Inc (UPB) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.68 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 54.67% per share during the next fiscal year.
Upstream Bio Inc (NASDAQ: UPB) Trading Performance Indicators
You can see what Upstream Bio Inc (UPB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 47.43.
Technical Analysis of Upstream Bio Inc (UPB)
Upstream Bio Inc (NASDAQ: UPB) saw its 5-day average volume 0.47 million, a positive change from its year-to-date volume of 0.28 million. As of the previous 9 days, the stock’s Stochastic %D was 25.83%. Additionally, its Average True Range was 0.91.
During the past 100 days, Upstream Bio Inc’s (UPB) raw stochastic average was set at 17.34%, which indicates a significant decrease from 24.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 98.43% in the past 14 days, which was lower than the 102.07% volatility it showed in the past 100 days.
Nevertheless, the first resistance level for the watch stands at $8.81 in the near term. At $9.41, the stock is likely to face the second major resistance level. The third major resistance level sits at $9.92. If the price goes on to break the first support level at $7.70, it is likely to go to the next support level at $7.19. The third support level lies at $6.59 if the price breaches the second support level.
Upstream Bio Inc (NASDAQ: UPB) Key Stats
There are 53,689K outstanding shares of the company, which has a market capitalization of 440.78 million. As of now, sales total 2,370 K while income totals -62,810 K. Its latest quarter income was 610 K while its last quarter net income were -15,990 K.
